Football
Barcelona see off Chelsea, Man Utd & PSG to land Vitor Roque
The Catalan giants and Athletico Paranaense have agreed a fee of €35 million (£30m/$38.4m) plus add-ons for the 18-year-old forward, National Daily understands. The fee could rise as high as €71m (£60m/$77m) in total, and Vitor Roque will arrive in Barcelona in 2024, with his move formally announced on Wednesday. It’s still not clear if the Brazilian will move in the January transfer window or next summer.
Vitor will sign a contract that runs until 2030 with a release clause of €500m (£427m/$551m). The transfer fee will be paid in instalments and will be the biggest in the history of Brazilian football. The bonuses are related to the number of matches played, goals scored and individual and team awards.
ALSO READ: Barcelona, Man United fined for breaking financial fair play rules
The deal, which has been weeks in the making, comes as something of a coup for Barcelona. Sporting director Deco is credited with helping see off competition from the likes of Chelsea, Man Utd, Bayern Munich and Paris Saint-Germain to secure the player.
The deal will come as a relief to Barca fans after losing out to bitter rivals Real Madrid for the signature of another 18-year-old in Arda Guler. Barca begin pre-season preparations in July as they head on tour to the United States.
-
Features7 days agoHow ADC leadership crisis put Atiku’s 2027 ambition at risk
-
Energy7 days agoNNPC plans 5–10% stock market listing, targets 2027 for IPO preparations
-
Business7 days agoLoveWorld Expo 2026 to showcase global innovations, emerging technologies in Lagos
-
Business4 days agoDisCos urge Minister to end blame game, apologise to Nigerians over blackouts
-
Latest7 days ago2027: No Court rulings can keep me off the ballot, Atiku insists
-
Latest1 week ago2027: Wike declares Obi’s political wave dead, dismisses chances of presidential victory
-
Latest1 week agoNDC faults Tinubu’s $7.7bn external loan request, raises debt concerns
-
Health5 days agoStudy links Pfizer COVID-19 vaccine to higher death rates than Moderna shot


